Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Boehringer Laboratory Illustrative image Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to ...

Germany's largest pharma company, today reported a currency-adjusted 6.1% gain in full-year 2024 revenues, buoyed by its ...

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and ...

With counterfeit drugs making up 30% of global sales, regulators are tightening serialisation and labelling rules to secure ...

At Reuters Pharma USA in Philadelphia, editor-in-chief Jonah Comstock caught up with Brian Hilberdink, the new head of US ...

The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...

Having a blueprint for supply chain resiliency is critical, as a mature and robust risk programme enables the right emergency ...

Elon Musk retains the top spot in Forbes’ Billionaires List 2025, with 288 fresh faces joining the rankings. See the newest ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Nearly three-quarters of the world’s billionaires are between the ages of 50 and 79. Just 12% are under 50. The rarest of all ...

The five youngest billionaires in the world this year, all heirs to their fortunes, collectively hold US$18.1 billion in wealth, according to Forbes’ latest annual ranking.